|
|
||||||||
From the First Department of Internal Medicine (Drs. Nakao, Motomura, Fukuda, Shiraishi, and Eguchi), Nagasaki University School of Medicine; Department of Neurology (Dr. Fukudome), Kawatana National Hospital; School of Health Sciences (Dr. Yoshimura), Nagasaki University; and Division of Neurology (Dr. Tsujihata), Nagasaki Kita Hospital, Japan.
Address correspondence and reprint requests to Dr. Katsumi Eguchi, the First Department of Internal Medicine, Nagasaki University School of Medicine, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan; e-mail: eguchi{at}net.nagasaki-u.ac.jp
The authors characterized the clinical and immunologic features of 110 patients with Lambert-Eaton myasthenic syndrome (LEMS). Anti-P/Q-type voltage-gated calcium channels (VGCC) antibodies were detected in 85% of the patients (seropositive) but not in the rest (seronegative). Except for the indication that small cell lung carcinoma is less common in seronegative patients, no significant differences were found in the clinical characteristics of patients who had or did not have anti-P/Q-type VGCC antibodies. The results of passive transfer experiments suggest that seronegative LEMS is also an autoantibody-mediated disorder.
This article has been cited by other articles:
![]() |
M. J. TITULAER and J. J.G.M. VERSCHUUREN Lambert-Eaton Myasthenic Syndrome: Tumor versus Nontumor Forms Ann. N.Y. Acad. Sci., June 1, 2008; 1132(1): 129 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.M. Warren, M. Bennett, M. Lai, J. Forty, and T.J. Walls Lambert-Eaton myasthenic syndrome associated with thymitis Neurology, January 11, 2005; 64(1): 168 - 169. [Full Text] [PDF] |
||||
![]() |
P. W. Wirtz, J. G. van Dijk, P. A. van Doorn, B. G.M. van Engelen, A. J. van der Kooi, J. B. Kuks, A. Twijnstra, M. de Visser, L. H. Visser, J. H. Wokke, et al. The epidemiology of the Lambert-Eaton myasthenic syndrome in the Netherlands Neurology, July 27, 2004; 63(2): 397 - 398. [Full Text] [PDF] |
||||
![]() |
M. Takamori, A. Abicht, H. Lochmuller, M. Motomura, Y. K. Nakao, T. Fukudome, T. Fukuda, H. Shiraishi, T. Yoshimura, M. Tsujihata, et al. What's in the serum of seronegative MG and LEMS? Neurology, July 22, 2003; 61(2): 277 - 278. [Full Text] [PDF] |
||||
![]() |
A. Abicht and H. Lochmuller What's in the serum of seronegative MG and LEMS?: MuSK et al. Neurology, December 10, 2002; 59(11): 1672 - 1673. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |